Why Johnson & Johnson Stock Sank Today
A recall of its baby powder sparked worries about the healthcare giant's asbestos-related legal battles.
Johnson & Johnson
JNJ
JNJ
$127.70
-$8.47
-6.2%
BATS BZX Real Time Price as of October 18, 2019, 4:00 p.m. EDT
View Interactive JNJ Charts
A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.
News & Analysis: Johnson & Johnson
The Fool has written over 2400 articles on Johnson & Johnson.
Stock Market News Today: Oct. 18, 2019
Atlassian's results aren't good enough, and Johnson & Johnson takes a hit to its reputation.
Johnson & Johnson (JNJ) Q3 2019 Earnings Call Transcript
JNJ earnings call for the period ending September 30, 2019.
Johnson & Johnson Settles Ohio Opioid Cases for $20.4 Million to Avoid Federal Trial
Does this mean anything for the pharmaceutical giant's long-term outlook?
3 Top Dividend Stocks to Buy in October
These companies could be long-term winners for your income-focused portfolio.
Better Buy: Gilead Sciences vs. Johnson & Johnson
Which stock wins in a battle between these two big drugmakers?
Johnson & Johnson Stock Upgraded Despite $8 Billion Risperdal Verdict: What You Need to Know
At least one analyst believes Johnson & Johnson's legal liabilities are vastly overstated.
This Healthcare Company Provides Shelter From a Volatile Market
Bad news is priced in, leaving behind value and growth.
3 Companies You Don't Realize Make Products You Use Every Day
You might be surprised how many of these companies' products are found in and around your home.
4 Reasons the Dow Will Hit 100,000 in 15 Years
A near-quadrupling in the Dow Jones Industrial Average is a very real possibility by 2035.
